Do Clinical Question Answering Systems Really Need Specialised Medical Fine Tuning?

Sushant Kumar Ray, Gautam Siddharth Kashyap, Sahil Tripathi, Nipun Joshi, [-0.4ex] Vijay Govindarajan, Rafiq Ali, Jiechao Gao, Usman Naseem, [-0.4ex] Jamia Hamdard, New Delhi, India, [-0.4ex] Cornell University, New York, USA, [-0.4ex] Expedia Group, USA, [-0.4ex] DSEU-Okhla, New Delhi, India, [-0.4 · 2026

Read Do Clinical Question Answering Systems Really Need Specialised Medical Fine Tuning? by Sushant Kumar Ray, Gautam Siddharth Kashyap, Sahil Tripathi, Nipun Joshi, [-0.4ex] Vijay Govindarajan, Rafiq Ali, Jiechao Gao, Usman Naseem, [-0.4ex] Jamia Hamdard, New Delhi, India, [-0.4ex] Cornell University, New York, USA, [-0.4ex] Expedia Group, USA, [-0.4ex] DSEU-Okhla, New Delhi, India, [-0.4 (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2601-12812.txt.

Introduction

Sushant Kumar Ray and a large team ask whether clinical question answering needs specialized medical fine tuning. Clinical QA systems increasingly rely on large language models. Deployment often assumes that domain specific fine tuning is essential for good answers. Specialized models like BioBERT, BioGPT, and PubMedBERT remain popular in the field.

Those specialized models face practical limits, the team note. They can have narrow coverage, high retraining costs, and limited adaptability. A general model might do as well without those burdens. The study tests that assumption head on. The answer guides hospitals weighing cost against accuracy in medical AI tools.

Catalog record

CREATORSushant Kumar Ray, Gautam Siddharth Kashyap, Sahil Tripathi, Nipun Joshi, [-0.4ex] Vijay Govindarajan, Rafiq Ali, Jiechao Gao, Usman Naseem, [-0.4ex] Jamia Hamdard, New Delhi, India, [-0.4ex] Cornell University, New York, USA, [-0.4ex] Expedia Group, USA, [-0.4ex] DSEU-Okhla, New Delhi, India, [-0.4
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2601-12812

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Do Clinical Question Answering Systems Really Need Specialised Medical Fine Tuning? Sushant Kumar Ray, Gautam Siddharth Kashyap, Sahil Tripathi, Nipun Joshi, [-0.4ex] Vijay Govindarajan, Rafiq Ali, Jiechao Gao, Usman Naseem, [-0.4ex] Jamia Hamdard, New Delhi, India, [-0.4ex] Cornell University, New York, USA, [-0.4ex] Expedia Group, USA, [-0.4ex] DSEU-Okhla, New Delhi, India, [-0.4ex] Center for SDGC, Stanford University, California, USA, [-0.4ex] Macquarie University, Sydney, Australia Abstract Clinical Question-Answering (CQA) industry systems are increasingly rely on Large Language Models (LLMs), yet their deployment is often guided by the assumption that domain-specific fine-tuning is essential. Although specialised medical LLMs such as BioBERT, BioGPT, and PubMedBERT remain popular, they face practical limitations including narrow coverage, high retraining costs, and limited adaptability. Efforts based on Supervised Fine-Tuning (SFT) have attempted to address these assumptions but continue to reinforce what we term the Specialisation Fallacy —the belief that specialised medical LLMs are inherently superior for CQA. To address this assumption, we introduce MedAssess-X , a deployment-industry-oriented CQA framework that applies alignment at inference time rather than through SFT. MedAssess-X uses lightweight steering vectors to guide model activations toward medically consistent reasoning without updating model weights or requiring domain-specific retraining. This inference-time alignment layer stabilises CQA performance across both general-purpose and specialised medical LLMs, thereby resolving the Specialisation Fallacy . Empirically, MedAssess-X delivers consistent gains across all LLM families, improving Accuracy by up to +6%, Factual Consistency by +7%, and reducing Safety Error Rate by as much as 50%. (a) Triage Misclassification Q: “Should the patient be prioritised for urgent care?” Issue: Specialised symptom-checker models ignored comorbidities mentioned in notes. Impact: Incorrect triage recommendation; safety risk. (c) Biased Literature Summary Q: “Summarise the latest evidence on diabetes management.” Issue: PubMed-tuned models focused only on RCTs, ignoring guideline updates. Impact: Outdated or incomplete summaries. (e) Misleading Patient Advice Q: “Can I take ibuprofen with my current medication?” Issue: Medication-tuned models failed to cross-check interactions. Impact: Unsafe patient guidance. Figure 1: Representative failure cases observed in industry CQA systems, including triage assistance, literature summarisation, and patient-facing guidance. These failure highlight how domain-specialised or fine-tuned models often struggle when applied beyond their narrow training scope, leading to (i) rigidity —inability to Specialisation Fallacy –relying solely on medically fine-tuned models does not guarantee reliable CQA performance in real-world deployments. This motivates the need for an inference-time alignment layer such as MedAssess-X , which stabilises reasoning across heterogeneous LLMs without domain-specific retraining. 1 Introduction Large Language Models (LLMs) have become foundational to Clinical Question-Answering (CQA) systems deployed across industries such as hospitals Singhal et al. 2023 , telehealth platforms Wang and Zhang 2024 , and biomedical information services Maity and Saikia 2025 . These systems support critical industry workflows such as triage assistance Nazi and Peng 2024 , literature summarisation Anisuzzaman et al. 2025 , and patient-facing guidance Maity and Saikia 2025 , where accuracy, consistency, and timely responses are essential (see Figure 1 ). As clinical knowledge evolves rapidly, healthcare organisations require CQA frameworks that are scalable, reliable, and adaptable to changing evidence and guidelines. Despite advances in general-purpose LLMs Shool et al. 2025 ; Zhang et al. 2025b , current deployment practices still rely heavily on the assumption that medical-domain fine-tuning is required for effective CQA. This belief has driven widespread adoption of specialised medical LLMs such as BioBERT Lee et al. 2020 , BioGPT Luo et al. 2022 , and PubMedBERT Gu et al. 2021 , which are designed to encode CQA context more explicitly. However, these specialised medical LLMs present several operational limitations in real-world industry settings–they cover narrow medical subdomains, require frequent retraining to stay up to date, and are costly to maintain within regulated clinical environments. Recent efforts based on Supervised Fine-Tuning (SFT) (e.g., He et al. 2025 ; Naseem et al. 2025 ) have improved task-specific performance but simultaneously reinforce what we term the Specialisation Fallacy —the assumption that specialised medical LLMs are inherently superior for all CQA tasks. To address this assumption, we propose MedAssess-X , a deployment-industry-oriented CQA framework that performs alignment at inference time rather than through additional fine-tuning such as SFT. Instead of updating model weights or training domain-specific variants, MedAssess-X injects lightweight steering vectors that guide model activations toward medically consistent reasoning during inference. This approach reduces dependence on specialised medical LLMs, simplifies maintenance, and provides a unified mechanism for stabilising behaviour across heterogeneous LLM families. In summary, our key contributions are as follows: • We introduce MedAssess-X , a deployment-industry-oriented CQA framework that resolves the Specialisation Fallacy by applying lightweight inference-time alignment through steering vectors. • We demonstrate that MedAssess-X delivers consistent empirical gains across heterogeneous LLMs—improving Accuracy by up to 6%, Factual Consistency by 7%, and reducing Safety Error Rate by nearly 50%—while adding only minimal computational overhead (7%–9% latency, \leq 6% memory, \leq 8% FLOPs), making it practical for real-world CQA deployments. 2 Related Works SFT for CQA. SFT has been the dominant effort for adapting LLMs to CQA. Early biomedical models such as BioBERT Lee et al. 2020 , PubMedBERT Gu et al. 2021 , and BioGPT Luo et al. 2022 demonstrated that domain-specific corpora could improve performance on specialised tasks including biomedical NER Alshaikhdeeb and Ahmad 2016 , evidence extraction Nye et al. 2018 , and CQA benchmarks Azeez et al. 2025 . Subsequent work extended this paradigm through instruction tuning Le et al. 2025 and domain-augmented datasets Jin et al. 2019 , enabling models to generate more clinically contextualised responses. However, these SFT-driven approaches impose substantial operational overhead as discussed in Section 1 . Moreover, fine-tuned models often fail when deployed outside their training distributions, reinforcing narrow reasoning behaviours and limiting flexibility in real-world CQA use cases (see Figure 1 ). These limitations contribute to what we describe as the Specialisation Fallacy . Inference-Time Alignment. Recent efforts has explored inference-time alignment that adjusts model behaviour without modifying underlying weights. Such approaches include activation editing Meng et al. 2022 , and soft prompt induction Sahoo et al. 2024 , which introduce small control vectors to influence model outputs Kashyap et al. 2025 . These mechanisms have shown promise in guiding factuality Youssef et al. 2025 ; Nadeem et al. 2025 , reasoning depth Wang et al. 2022 ; Zhang et al. 2025a , and safety alignment in general-purpose LLMs while avoiding retraining costs Li et al. 2025 ; Maskey et al. 2025 ; Ren et al. 2025 . Despite this progress, the application of inference-time steering to CQA remains underexplored. Existing methods do not provide a unified alignment layer capable of stabilising behaviour across heterogeneous general-purpose and specialised medical LLMs. Our work fills this gap by introducing MedAssess-X , the deployment-industry-oriented framework that applies steering-vector alignment at inference time to stabilise medical reasoning. Figure 2: MedAssess-X framework operates as an activation-level alignment layer that sits between the base LLM and its final decoding stages. Instead of updating model parameters through SFT, the framework introduces lightweight steering vectors that modulate hidden representations during inference to produce medically consistent reasoning trajectories. 3 Methodology In this section, we describe MedAssess-X , our proposed deployment-industry-oriented framework for aligning CQA models at inference time (see Figure 2 ). 3.1 Problem Formulation Let \mathbf{x} denote a CQA input, consisting of a

Read the complete text